18 October 2024 in La Revue de Médecine Interne
CTClaire Triffault-Fillit
+2
Fever is a cosmopolit zoonosis due to Coxiella burnetii. The diagnosis of chronic Q fever can be really misleading. The growth of this bacterium is difficult and blood cultures are often negatives. We rapport here the case of a 69-year-old man presenting with an alteration of his general condition and low back pain. He suffered from a well-controlled HIV infection and lower limb arteriopathy treated with a cross-femoral bypass. A computed tomography scan revealed a L3-L4 abscessed spondylodiscitis but multiple blood cultures remained sterile, and the transthoracic echocardiography was normal. PET scan showed a hypermetabolism on L3-L4 vertebrae but also indicated an intense uptake of the cross-femoral bypass. C. burnetii serology was in favour of a chronic Q fever. The management of this chronic Q fever needed a multidisciplinary discussion. Three months after the treatment initiation, C. burnetii serology was reduced by a titer and has stabilized 6months to a year. Chronic Q fever and mostly osteoarticular diseases are difficult to diagnose. We have to evoke the diagnosis of osteoarticular chronic Q fever in case of insidious inflammatory syndrome, negatives blood cultures spondylodiscitis especially when associated to endocarditis or vascular infection, and in case of spondylodiscitis with a granulomatous histology without Mycobacterium tuberculosis. Although there are many complementary tests (PET scanner, PCR), serology remains the cornerstone of diagnosis.
5 March 2026 in La Revue de Médecine Interne
Inflammatory enteropathies are frequent in primary immune deficiencies (PID) (up to 21%). Their pathophysiology is complex and combines immune abnormalities (loss of tolerance, deficit in mucosal IgA secretion and altered infectious response) with an abnormal environment (dysbiosis, production of pro-inflammatory endotoxins, epigenetic and epitranscriptomic alterations). This leads to a deregulated inflammatory state of the gastrointestinal tract and thus to enteropathy. These conditions are heterogeneous and manifest not only as an inflammatory bowel disease but also as in lymphocytic, autoimmune, or eosinophilic colitis. Most of the time PID associated enteropathies remain unspecified. Their clinical, biological, and scannographic features are difficult to distinguish from enteropathies in immunocompetent patients. However, some histological specificities are described including graft-versus-host disease phenotype, with apoptotic bodies, and absence of mucosal plasma cells. There is no standardized treatment for this specific condition. Treatments of inflammatory bowel disease in immunocompetent patients are usually used, although refractory cases are more frequent. This entity is associated with an increased risk of autoimmune manifestations notably including autoimmune cytopenia. Finally, IBD in PID are associated with an increased risk of death related to the enteropathy and its treatments.